About
About BioFutureRx
BioFutureRx is a biopharmaceutical company focused on biologic medicines. Through a strategic development and manufacturing partnership, we advance a broad portfolio of biosimilars, antibodies, diagnostics, and delivery platforms — and we engineer our own peptide therapeutics in-house, led by BFRx3711. Our team brings decades of combined experience in drug development, biologics, and the partnerships that bring new medicines to patients.
Leadership
The team behind the science
Rob Camerer
Chairman & Managing Director
Rob leads BioFutureRx's strategy across its biologics portfolio and in-house peptide pipeline, drawing on decades in pharmaceutical development and business development. He directs the company's mission to bring biosimilars, novel antibodies, and its own peptide therapeutics to patients.
View profile
Dr. Gopal Venkatesan
Chief Executive Officer
Gopal leads the scientific development of BioFutureRx's pipeline, pairing deep technical insight with development experience. He directs the company's biologics and peptide-design work — including development strategy for BFRx3711 — from molecular engineering and preclinical science through regulatory pathway.
View profile
Jonathan Camerer
Executive Vice President
Jonathan manages BioFutureRx's corporate development and program operations, guiding the company's partnering and financing discussions from first contact through structured agreements.
View profile
Joshua Camerer
Business Development Manager
Joshua drives front-line business development — managing outreach to prospective strategic partners and investors and supporting the financing of BioFutureRx's programs.
View profile